GO:0007254 JNK cascade: Stress-Activated MAPK Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007254 (JNK cascade) is a biological process describing a MAPK cascade that contains at least the JNK (MAPK8) MAP kinase and is activated by stress signals, G protein-coupled receptors, growth factors, and cytokines.
• The cascade proceeds through tiered kinase activation: MAP4K to MAP3K to MAP2K (JNKK) to JNK, with each tier phosphorylating and activating the next.
• JNK cascade signaling drives context-dependent outcomes including cell proliferation, differentiation, apoptosis, and inflammation [1,6].
• Dysregulated JNK signaling is implicated in cancer, Alzheimer's disease, psoriasis, and responses to hyperthermia [2,3,4,8].
• The JNK cascade can display bistable behavior, meaning it can switch between distinct stable activity states.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are key tools for dissecting JNK cascade gene function.
Description
The JNK cascade (GO:0007254) is a stress-activated MAP kinase signaling module that converts extracellular and intracellular cues into transcriptional and apoptotic responses. It is defined as a MAPK cascade containing at least the JNK (MAPK8) MAP kinase, initiated by activation of a MAP3K (JUN3K), which activates JNKK (a MAP2K), which in turn activates JNK; an additional upstream MAP4K tier can also be present. The cascade is activated by stress signals as well as by G protein-coupled receptors, growth factors, and cytokines, and it results in cellular responses such as cell proliferation, cell differentiation, apoptosis, and inflammation. Because JNK signaling sits at the intersection of stress sensing and cell fate decisions, it is a central topic in cancer biology, neuroscience, immunology, and dermatology [2,3,4,6]. Understanding its mechanism, regulation, and disease relevance requires precise genetic models and pathway-level readouts.
JNK cascade At A Glance
| GO ID | GO:0007254 |
|---|---|
| GO term | JNK cascade |
| Ontology | biological_process |
| Synonym | c-Jun N-terminal kinase cascade; JNK1 cascade; JNK2 cascade; JNK3 cascade; MAPK10 cascade; MAPK8 cascade; MAPK9 cascade; SAPK cascade; stress-activated protein kinase cascade |
| Major function | Stress-activated MAPK signaling that regulates proliferation, differentiation, apoptosis, and inflammation |
| Upstream activators | Stress signals, G protein-coupled receptors, growth factors, and cytokines |
| Kinase tiers | MAP4K (optional), MAP3K (JUN3K), MAP2K (JNKK), MAPK (JNK/MAPK8) |
| Key downstream target | c-Jun, linking JNK activity to transcriptional responses [2,4] |
| Cellular outcomes | Apoptosis, inflammation, proliferation, differentiation [1,3,6] |
What Is GO:0007254?
In simple terms, the JNK cascade is a relay of kinases that passes a signal from the cell surface to the nucleus, ending with activation of the JNK protein. According to the QuickGO definition, GO:0007254 describes a MAPK cascade containing at least the JNK (MAPK8) MAP kinase. It starts with activation of JUN3K (a MAP3K), which activates JNKK (a MAP2K), which in turn activates JNK. The cascade can also contain an additional upstream tier, the MAP4K. The kinases in each tier phosphorylate and activate the kinases in the downstream tier. The JNK cascade is activated by stress signals, as well as by G protein-coupled receptors, growth factors, and cytokines, and results in cellular responses such as cell proliferation, cell differentiation, apoptosis, and inflammation.
Why Is JNK cascade Important in Cell Biology?
The JNK cascade is important because it is a central stress-responsive signaling pathway that determines whether cells survive, proliferate, differentiate, or die. Its activation by G protein-coupled receptors and stress signals can trigger apoptosis, a mechanism with direct implications for cancer therapy and tissue injury. In disease contexts, JNK/c-Jun cascade activity has been linked to Alzheimer's disease pathology, malignant proliferation in psoriasis, and chemotherapeutic responses in oral cancer [2,3,4]. The pathway also interacts with NF-kappaB signaling to control programmed cell death, making it a key node in inflammation and immune regulation. Because of this broad relevance, JNK cascade components are attractive targets for experimental perturbation and therapeutic exploration.
• Controls stress-induced apoptosis through GqPCR signaling and caspase cascade activation [1,3].
• Regulates malignant proliferation of psoriatic keratinocytes via ROS and mitochondrial membrane potential.
• Implicated in Alzheimer's disease through the JNK/c-Jun cascade.
• Modulates NF-kappaB-mediated control of programmed cell death in health and disease.
• Displays bistable behavior, enabling switch-like cellular decisions.
• Mediates hyperthermia-induced stress signaling.
• Contributes to inflammation and cytokine responses.
• Provides targets for cancer therapy through apoptosis induction.
• Connects WNT-related disease biology to stress kinase signaling.
• Serves as a model system for MAPK cascade architecture and kinetics.
What Happens During JNK cascade?
Activation by Stress, GPCRs, Growth Factors, and Cytokines
In simple terms: The pathway is switched on when the cell receives stress or growth signals from outside.
The JNK cascade is activated by stress signals, as well as by G protein-coupled receptors, growth factors, and cytokines. GqPCR signaling can induce JNK cascade-dependent apoptosis, demonstrating that G protein-coupled receptors are direct upstream inputs. This diversity of activators allows the pathway to integrate environmental and physiological cues into a unified cellular response.
Tiered Kinase Relay: MAP4K to MAP3K to MAP2K to JNK
In simple terms: A series of kinases passes the signal down like a relay race until JNK is switched on.
The cascade starts with the activation of JUN3K (a MAP3K), which activates JNKK (a MAP2K), which in turn activates JNK. The cascade can also contain an additional tier, the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinases in the downstream tier, ensuring signal amplification and specificity.
JNK Activation and c-Jun Phosphorylation
In simple terms: Once JNK is active, it modifies target proteins such as c-Jun to change gene expression.
Activated JNK phosphorylates downstream targets including c-Jun, forming the JNK/c-Jun cascade [2,4]. This cascade activation enhances malignant proliferation of psoriatic keratinocytes by regulating ROS levels and mitochondrial membrane potential. In Alzheimer's disease, the JNK/c-Jun cascade has been implicated in pathological signaling.
Apoptosis and Caspase Cascade Activation
In simple terms: Under certain conditions, the JNK signal tells the cell to self-destruct.
JNK cascade-induced apoptosis is a unique role in GqPCR signaling. Narciclasine induces caspase cascade activation and cell apoptosis via JNK signaling in oral cancer, linking the cascade to therapeutic cell death. The NF-kappaB-mediated control of the JNK cascade further modulates the antagonism of programmed cell death in health and disease.
Bistability and Signal Dynamics
In simple terms: The pathway can flip between two stable states rather than responding gradually.
The JNK cascade exhibits bistability, meaning it can adopt distinct stable activity states. This property may underlie switch-like cellular decisions such as survival versus apoptosis. Understanding these dynamics is important for predicting pathway behavior under experimental perturbation.
Stress Responses Including Hyperthermia
In simple terms: Physical stress such as heat can preferentially engage JNK signaling.
JNK signaling dominance has been observed in hyperthermia, indicating that heat stress is a potent activator of this cascade. This connects the JNK cascade to cellular stress chaperone responses. Such stress-specific activation patterns are relevant for understanding how cells cope with environmental insults.
Key Genes Involved in GO:0007254 JNK cascade
The following genes and proteins are core components or well-documented regulators/effectors of the JNK cascade (GO:0007254).
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAPK8 (JNK1) | Core MAP kinase of the JNK cascade | Defining kinase of GO:0007254; knockout models reveal stress responses |
| MAPK9 (JNK2) | JNK family MAP kinase | Synonym JNK2 cascade; contributes to apoptosis and inflammation |
| MAPK10 (JNK3) | JNK family MAP kinase | Synonym JNK3 cascade; neuronal stress signaling |
| JUN | Downstream transcription factor phosphorylated by JNK | JNK/c-Jun cascade in Alzheimer's disease and psoriasis [2,4] |
| MAP3K (JUN3K) | Upstream MAP3K that activates JNKK | Initiating tier of the cascade |
| JNKK (MAP2K) | MAP2K that activates JNK | Required relay kinase in the cascade |
| MAP4K | Optional upstream tier kinase | Adds additional regulatory input to the cascade |
| NF-kappaB components | Modulate JNK cascade and programmed cell death | Antagonism of apoptosis in health and disease |
| GqPCR signaling proteins | Upstream activators of JNK apoptosis | Unique role in GqPCR-induced apoptosis |
| ROS regulators | Modulate JNK/c-Jun-driven proliferation | Psoriatic keratinocyte malignancy |
| Mitochondrial membrane potential regulators | Linked to JNK/c-Jun proliferation effects | Psoriasis research |
| Caspase cascade components | Execute apoptosis downstream of JNK | Oral cancer therapy studies |
| WNT pathway components | Cross-talk with stress signaling | WNT-related human diseases |
| Heat shock/chaperone proteins | Respond to hyperthermia with JNK dominance | Cell stress chaperone research |
| Bistability network components | Generate switch-like JNK dynamics | Quantitative signaling studies |
How Is JNK cascade Regulated?
The JNK cascade is regulated at multiple levels. NF-kappaB-mediated control of the JNK cascade modulates the antagonism of programmed cell death in health and disease, indicating cross-talk between inflammatory signaling and JNK activity. The cascade can also display bistability, meaning its activity can switch between distinct stable states rather than changing linearly. Upstream inputs from G protein-coupled receptors, growth factors, and cytokines provide additional regulatory control. ROS levels and mitochondrial membrane potential are also involved in regulating JNK/c-Jun cascade-driven proliferation in psoriatic keratinocytes. Hyperthermia can shift signaling dominance toward JNK, further illustrating stress-dependent regulation.
JNK cascade and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAPK8 (JNK1) | Cancer and stress-induced apoptosis | Knockout cell lines and xenograft models |
| JUN | Alzheimer's disease | Neuronal cell models with point mutations |
| MAPK9 (JNK2) | Oral cancer apoptosis | Cancer cell lines treated with JNK activators |
| MAPK10 (JNK3) | Psoriasis and hyperproliferation | Keratinocyte overexpression models |
| NF-kappaB components | Inflammation and programmed cell death | Knock-in reporter models |
JNK Cascade in Cancer
JNK cascade-induced apoptosis plays a unique role in GqPCR signaling, and this mechanism can be exploited for cancer therapy. Narciclasine induces caspase cascade activation and cell apoptosis via JNK signaling in oral cancer, demonstrating that pharmacological JNK activation can kill cancer cells. These findings support the JNK cascade as a therapeutic target in oncology [1,3].
JNK Cascade in Neurodegeneration
The JNK/c-Jun cascade has been implicated in Alzheimer's disease, linking stress kinase signaling to neurodegenerative pathology. This connection suggests that modulating JNK activity could influence neuronal survival and disease progression. Further research is needed to define the precise molecular contributions.
JNK Cascade in Inflammatory Skin Disease
JNK/c-Jun cascade activation enhances malignant proliferation of psoriatic keratinocytes by regulating ROS levels and mitochondrial membrane potential. This identifies the cascade as a driver of hyperproliferative skin pathology. Targeting this pathway may offer therapeutic benefit in psoriasis.
JNK Cascade and Cell Death Control
The NF-kappaB-mediated control of the JNK cascade is central to the antagonism of programmed cell death in health and disease. This regulatory interaction determines whether cells survive or undergo apoptosis. Dysregulation of this balance contributes to multiple disease states.
From JNK cascade-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is MAPK8 required for stress-induced apoptosis? | MAPK8 knockout cell line |
| Does a specific JNK phosphorylation site on c-Jun drive proliferation? | JUN point-mutation knock-in [2,4] |
| Can JNK cascade activation be monitored in live cells? | Tagged knock-in reporter |
| Does overexpression of JNK3 enhance keratinocyte proliferation? | Overexpression cell model |
| Which upstream MAP3K initiates the cascade? | MAP3K knockout or knockdown |
| How does hyperthermia alter JNK signaling dominance? | Heat-shock treated knockout and wild-type cells |
How to Study the JNK cascade Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes | Identifying JNK target genes in disease models [2,4] |
| Phosphoproteomics | Kinase tier phosphorylation | Mapping cascade activation |
| Caspase activity assay | Apoptosis execution | Cancer therapy response |
| Live-cell biosensor imaging | Real-time JNK activity dynamics | Bistability studies |
| ROS measurement | Oxidative stress levels | Psoriasis keratinocyte proliferation |
| Mitochondrial membrane potential assay | Mitochondrial function | JNK-driven proliferation studies |
| Heat-shock treatment assays | Stress response dominance | Hyperthermia signaling |
RNA-seq and Transcriptomics
RNA-seq can measure global transcriptional changes downstream of JNK cascade activation, including c-Jun target genes [2,4]. This approach is useful for identifying pathways that cooperate with JNK signaling in disease models such as psoriasis and Alzheimer's disease [2,4].
Proteomics and Phosphoproteomics
Phosphoproteomics can quantify phosphorylation events across the kinase tiers of the JNK cascade, from MAP4K to MAP3K to MAP2K to JNK. This is essential for mapping pathway activation states and identifying off-target effects of perturbations.
Apoptosis and Caspase Assays
Caspase cascade activation and apoptosis assays are used to measure JNK-dependent cell death in cancer models. These readouts link JNK signaling directly to therapeutic outcomes.
Live-Cell Imaging and Biosensors
Live-cell imaging of JNK activity biosensors can reveal bistable dynamics and real-time pathway behavior. Such methods are valuable for studying signal dynamics in single cells.
How CRISPR Can Be Used to Study GO:0007254 JNK cascade
Knockout
CRISPR knockout of MAPK8, MAPK9, or MAPK10 can abolish specific JNK cascade branches, allowing researchers to test which JNK isoform mediates a given response. Knockout of upstream MAP3K or MAP2K components can define the minimal cascade required for apoptosis or proliferation.
Point Mutation
Point mutations can be introduced into JNK phosphorylation sites on c-Jun or into kinase domains of cascade components to test causality [2,4]. This approach is particularly useful for separating phosphorylation-dependent from independent functions.
Knock-in
Knock-in of tagged JNK or reporter alleles enables real-time monitoring of cascade activity and protein localization. Tagged knock-in models are valuable for studying bistable dynamics and pathway kinetics.
Overexpression
Overexpression of JNK cascade components such as MAPK10 can enhance pathway output and model disease states like psoriatic hyperproliferation. Overexpression models are also used to test whether a gene is sufficient to drive apoptosis or inflammation [1,3].
How EDITGENE Supports JNK cascade Research
Researchers studying JNK cascade-related genes often need to determine whether a candidate gene is causally involved in stress signaling, apoptosis, or proliferation. EDITGENE provides the CRISPR tools and cell models required to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for JNK cascade research.
Frequently Asked Questions About JNK cascade
What is the JNK cascade (GO:0007254)?
The JNK cascade is a MAPK cascade containing at least the JNK (MAPK8) MAP kinase, activated by stress signals, G protein-coupled receptors, growth factors, and cytokines, and leading to proliferation, differentiation, apoptosis, or inflammation.
What genes are involved in the JNK cascade?
Core genes include MAPK8, MAPK9, MAPK10, JUN, and upstream MAP3K, MAP2K, and MAP4K components [1,2,4].
How is the JNK cascade activated?
It is activated by stress signals, G protein-coupled receptors, growth factors, and cytokines through tiered kinase phosphorylation.
What diseases are linked to the JNK cascade?
It has been linked to cancer, Alzheimer's disease, psoriasis, and inflammatory conditions [1,2,3,4,6].
What is the role of JNK in apoptosis?
JNK cascade-induced apoptosis is a unique role in GqPCR signaling and can be triggered by compounds such as narciclasine in oral cancer [1,3].
What does bistability in the JNK cascade mean?
Bistability means the cascade can switch between two stable activity states, enabling switch-like cellular decisions.
How does NF-kappaB regulate the JNK cascade?
NF-kappaB-mediated control of the JNK cascade modulates the antagonism of programmed cell death in health and disease.
Is the JNK cascade involved in psoriasis?
Yes, JNK/c-Jun cascade activation enhances malignant proliferation of psoriatic keratinocytes by regulating ROS and mitochondrial membrane potential.
How can I study the JNK cascade with CRISPR?
Knockout, point mutation, knock-in, and overexpression models can be used to test causality of specific cascade components [1,4,5].
What is the relationship between JNK and hyperthermia?
JNK signaling dominance has been observed in hyperthermia, indicating heat stress strongly activates this cascade.
Conclusion
The JNK cascade (GO:0007254) is a stress-activated MAPK signaling module with broad roles in apoptosis, proliferation, inflammation, and differentiation. Its dysregulation is implicated in cancer, neurodegeneration, and inflammatory skin disease, making it a high-value target for experimental and therapeutic research [2,3,4,6]. CRISPR-based models and pathway-level readouts provide the tools needed to dissect its mechanism and regulation.
References
- 1. Nadel G et al.. 2023. JNK Cascade-Induced Apoptosis-A Unique Role in GqPCR Signaling.. Int J Mol Sci 24(17) PMID: 37686335
- 2. Okazawa H et al.. 2002. The JNK/c-Jun cascade and Alzheimer's disease.. Am J Alzheimers Dis Other Demen 17(2):79-88 PMID: 11954673
- 3. Su CW et al.. 2025. Narciclasine Induces Caspase Cascade Activation and Cell Apoptosis via JNK Signaling in Oral Cancer.. Am J Chin Med 53(8):2579-2598 PMID: 41362219
- 4. Zhang Y et al.. 2025. JNK/c-Jun cascade activation enhances malignant proliferation of psoriatic keratinocytes by regulating ROS levels and mitochondrial membrane potential.. Eur J Med Res 30(1):754 PMID: 40826129
- 5. Bagowski CP et al.. 2001. Bistability in the JNK cascade.. Curr Biol 11(15):1176-82 PMID: 11516948
- 6. Papa S et al.. 2006. The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease.. Cell Death Differ 13(5):712-29 PMID: 16456579
- 7. Katoh M et al.. 2017. Molecular genetics and targeted therapy of WNT-related human diseases (Review).. Int J Mol Med 40(3):587-606 PMID: 28731148
- 8. Enomoto A et al.. 2025. JNK signaling dominance in hyperthermia.. Cell Stress Chaperones 30(4):100080 PMID: 40339685
